Cognitive Behavioral Therapy News and Research

RSS

Combining psychotherapy with antidepressants does not improve outcomes in severely depressed patients

Antidepressants are the first-choice treatment for severe depression. Antidepressant use is often supplemented by psychotherapy.

6 Jun 2022

Black youth in racist communities less likely to benefit from psychotherapy

A study in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), published by Elsevier, reports that Black youth living in communities with high (vs. low) anti-Black racism are less likely to benefit from psychotherapy ("talk therapy;" such as cognitive behavioral therapy).

2 Jun 2022

Non-pharmaceutical help should be offered for pain, fatigue, anxiety at the time of MS diagnosis

Two recently published studies by UW Medicine researchers indicate that clinicians should offer non-pharmaceutical help for pain, fatigue, depression, or anxiety at the time of diagnosis for patients with multiple sclerosis, rather than wait.

30 May 2022

RED-D intervention reduces unplanned hospital readmissions for individuals with depressive symptoms

Results from a new study at Boston Medical Center show how transition support and post-discharge depression treatment reduce unplanned hospital readmissions for individuals with depressive symptoms.

25 May 2022

Personal construct therapy found to be effective in reducing depression in women with fibromyalgia

Fibromyalgia is a rheumatic disease of unknown origin, which is characterized by chronic pain and often accompanied by symptoms of depression. It mainly affects women, and there is no cure, but various treatments can help relieve the symptoms.

9 May 2022

Two in five adults with ADHD found to be in excellent mental health

A new nationally representative study published online in the International Journal of Applied Positive Psychology found two in five adults (42%) with attention deficit hyperactivity disorder (ADHD) were in excellent mental health.

12 Apr 2022

Insomnia common in heart disease patients and linked with subsequent cardiovascular events

Nearly half of heart disease patients have insomnia, according to research presented at ESC Preventive Cardiology 2022, a scientific congress of the European Society of Cardiology, and published in SLEEP Advances.

7 Apr 2022

Insufficient sleep could play a role in the development of type 2 diabetes

People who have difficulty getting to sleep or staying asleep had higher blood sugar levels than people who rarely had sleep issues, new research has found.

6 Apr 2022

Cleveland Clinic launches new study exploring the link between epilepsy and stress

Cleveland Clinic has launched an innovative study exploring the link between epilepsy and stress, supported by a $5.5 million donation from the Charles L. Shor Foundation.

1 Mar 2022

Study describes trajectories of insomnia symptoms from childhood through young adulthood

Children with insomnia symptoms are likely to persist with them as young adults and are significantly more likely to develop an insomnia disorder in early adulthood compared to children who do not have difficulty sleeping, according to new research led by scientists at Penn State College of Medicine.

17 Feb 2022

Treatment found to be safe, efficacious in improving insomnia and night sweats among midlife women

Hot flashes and night sweats are a common cause of insomnia among peri- and postmenopausal women. Hot flashes, night sweats and insomnia are all linked to reduced quality of life and distress.

17 Feb 2022

Study finds higher levels of oxytocin in men with hypersexual disorder

Men with hypersexual disorder may have higher levels of oxytocin in their blood than men without the disorder, according to a small study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

2 Feb 2022

Intervention focusing on one's strength may be the best way to improve sad mood

What's the best way to improve a sad mood? It may be whatever skill you think you're best at, a new study suggests.

21 Jan 2022

AAN issues new guideline on oral and topical treatments for painful diabetic neuropathy

Diabetic neuropathy refers to nerve damage due to diabetes and it may lead to pain and numbness, most often in the hands and feet. To help neurologists and other doctors determine the best treatment for people with diabetic neuropathy, the American Academy of Neurology (AAN) has issued a guideline on oral and topical treatments for painful diabetic neuropathy.

28 Dec 2021

One in four adults with ADHD found to have generalized anxiety disorder

A new nationally representative study published online in the Journal of Affective Disorders found that one in four adults aged 20-39 with attention deficit hyperactivity disorder (ADHD) had generalized anxiety disorder (GAD).

18 Nov 2021

Exercise can alleviate symptoms of anxiety, study shows

Both moderate and strenuous exercise alleviate symptoms of anxiety, even when the disorder is chronic, a study led by researchers at the University of Gothenburg shows.

9 Nov 2021

Study finds fewer psychological symptoms among cardiac arrest survivors practicing mindfulness

Cardiac arrest survivors who are more mindful, or aware of the present in a nonjudgmental way, reported fewer symptoms of depression, anxiety and post-traumatic stress disorder than survivors who are less mindful, according to preliminary research to be presented at the American Heart Association's Resuscitation Science Symposium (ReSS) 2021.

8 Nov 2021

Johns Hopkins Medicine awarded NIH grant to explore the impacts of psilocybin on tobacco addiction

Johns Hopkins Medicine was awarded a grant from the National Institutes of Health (NIH) to explore the potential impacts of psilocybin on tobacco addiction.

18 Oct 2021

Moment-to-moment fluctuations in brain activity can reliably predict psychiatric treatment outcomes

It remains a central challenge in psychiatry to reliably judge whether a patient will respond to treatment.

14 Oct 2021

JDRF announces new grant to explore methods to alleviate diabetes distress

JDRF, the leading global nonprofit funder of type 1 diabetes (T1D) research, announces a new grant awarded to Albert Einstein College of Medicine and Montefiore Health System. Led by endocrinologist Shivani Agarwal, M.D., M.P.H., and by psychologist Jeffrey Gonzalez, Ph.D., the study will utilize telemedicine to deliver cognitive behavioral therapy to young adults with T1D to reduce diabetes-related distress.

30 Sep 2021